Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
How do you sequence ADT relative to radiation for a low volume M1 prostate cancer?
Concurrent? Neoadjuvant and concurrent? If neoadjuvant, how long before?
Answer from: Radiation Oncologist at Community Practice
Start with radiotherapy, carry on hormone therapy for up to two years.
Sign in or Register to read more
6638
Related Questions
How do you decide between internal versus external decompression of malignant obstruction of the ureter (MUO)?
How do you manage LUTS in the post-prostatectomy setting?
How would you approach a patient with prostate cancer with PSMA+ non-regional lymph nodes?
For gross hematuria from a primary bladder tumor, what palliative radiation regimen would you recommend?
How do you talk to patients with intermediate-risk prostate cancer deciding between LDR brachytherapy (monotherapy) vs HDR mono vs SBRT vs EBRT, in terms of the comparative side effect profile of each approach?
How do you manage significant gas in patients undergoing pelvic radiotherapy?
In patients who have residual bladder tumors after maximal TURBT, would you boost the GTV above typical doses, 55 Gy/20 fractions or 64 Gy/32 fractions, assuming you can meet constraint?
Do you ever dose escalate radiotherapy to the primary in low volume metastatic prostate cancer?
How would you manage incidentally-found prostate cancer on TURP?
When following active surveillance paradigm, what PSA increase will trigger prostate biopsy?